Results 51 to 60 of about 18,628 (145)

Role of Neuroimaging Before Coronary Angiography in Patients With Out‐of‐Hospital Cardiac Arrest

open access: yesCatheterization and Cardiovascular Interventions, Volume 108, Issue 2, Page 533-539, August 1, 2026.
ABSTRACT Background Patients presenting following out‐of‐hospital cardiac arrest (OOHCA) often require emergency coronary angiography. Presentations can be associated with syncope or head‐trauma. Aims We investigated the impact and utility of pre‐coronary angiography CT‐Brain (CT‐B) in patients following OOHCA on clinical outcomes.
Edmond Wong   +8 more
wiley   +1 more source

Incidencia de trombosis de stents coronarios en el «mundo real» Incidence of coronary stent thrombosis in the «real world»

open access: yesRevista Colombiana de Cardiología, 2010
ANTECEDENTES: la evidencia disponible de stents liberadores de medicamento proviene de estudios controlados con estrictos criterios de inclusión, limitando sus conclusiones y haciendo difícil la aplicación de sus resultados en el mundo real.
Bernardo Lombo   +7 more
doaj  

Análise de impacto do stent farmacológico no orçamento do sistema único de saúde Impact analysis of drug-eluting stent in the unified health system budget

open access: yesArquivos Brasileiros de Cardiologia, 2007
FUNDAMENTO: Stents farmacológicos representam opção adicional para o tratamento da doença arterial coronariana. Essa tecnologia representa importante inovação, para a qual pode ser necessário financiamento adicional, no curto prazo, para permitir ...
Denizar Vianna Araújo   +2 more
doaj   +1 more source

Microaxial Flow Pump Support as a Bridge to Transaxillary TAVI‐In‐TAVI in Cardiogenic Shock

open access: yesClinical Case Reports, Volume 14, Issue 8, August 2026.
ABSTRACT A 79‐year‐old man presented with cardiogenic shock due to severe degeneration of a prior transcatheter aortic valve. Temporary mechanical circulatory support with a transvalvular microaxial flow pump was initiated, resulting in rapid stabilization.
Matteo Orlandi   +9 more
wiley   +1 more source

Actual problems of stenting using in critical limb ischemia (cli) treatment

open access: yesЕндоваскулярна нейрорентгенохірургія, 2017
Critical limb ischemia is a life-threatening disease that often results in partial disability or death. One of the ways in optimizing its endovascular treatment is the stents using.
O.L. Nikishin   +4 more
doaj   +1 more source

A Therapeutic Dilemma: Catastrophic ST‐Elevation Myocardial Infarction Following Antiplatelet Therapy Interruption in a Patient With JAK2‐Positive Polycythemia Vera

open access: yesClinical Case Reports, Volume 14, Issue 8, August 2026.
Premature interruption of dual antiplatelet therapy in a patient with polycythemia vera and clinically suspected acquired von Willebrand syndrome triggered catastrophic recurrent stent thrombosis, whereas perioperative bridging with eptifibatide enabled safe surgery. ABSTRACT Polycythemia vera is associated with a thrombotic–hemorrhagic paradox.
Behrouz zarei   +2 more
wiley   +1 more source

Very late stent thrombosis of Sirolimus-eluting stent 59 months after implantation: A first report from the Middle-East and review of literature

open access: yesHeart Views, 2011
Very late stent thrombosis occurs more frequently with drug-eluting stents and tends to occur despite dual antiplatelet therapy or after long periods of clopidogrel discontinuation.
Prashanth Panduranga   +1 more
doaj   +1 more source

Impella‐Assisted High‐Risk Percutaneous Coronary Intervention in Cardiogenic Shock With Low‐Flow, Low‐Gradient Aortic Stenosis and Multivessel Coronary Artery Disease: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 8, August 2026.
ABSTRACT Patients with cardiogenic shock, low‐flow, low‐gradient aortic stenosis, and multivessel coronary artery disease who are ineligible for surgery present a major therapeutic challenge. Percutaneous mechanical circulatory support may facilitate revascularization in this high‐risk population. A 69‐year‐old man presented after a mechanical fall and
Douni Roger   +3 more
wiley   +1 more source

Bioresorbable Scaffolds for Coronary Arteries: Where Do We Stand Today?

open access: yesVIEW Medicine, Volume 1, Issue 1, August 2026.
Bioresorbable coronary scaffolds are moving from thick strut pitfalls to thinner, stronger, healing‐oriented designs. Integrating advances in materials, guided implantation with preparation, size, and postdilation steps, and resorption aligned to healing, we synthesize clinical evidence and chart a roadmap toward intelligent, transient platforms ...
Junya Matsuda   +5 more
wiley   +1 more source

A novel platinum chromium everolimus-eluting stent for the treatment of coronary artery disease

open access: yesBiologics: Targets & Therapy, 2013
Johan Bennett, Christophe DuboisDepartment of Cardiovascular Diseases, University Hospitals Leuven, Leuven, BelgiumAbstract: The development of coronary stents represents a major step forward in the treatment of obstructive coronary artery disease since ...
Bennett J, Dubois C
doaj  

Home - About - Disclaimer - Privacy